Biomarck is pleased to announce its inclusion on COVID-19 Drug Treatment Trackers: Milken Institute COVID-19 Treatment and Vaccine Tracker | Artis Ventures


Biomarck Pharmaceuticals presentation at H.C. Wainwright 2021 Global Life Sciences Conference on March 9-10, 2021

View presentation

Peptide Inhibitors of MARCKS Reverse Endotoxin Induced Uveitis in Rats presented at ARVO on May 6, 2021

Download presentation

A Phase II, Placebo-Controlled, Multicenter Pilot Study to Evaluate the Safety and Efficacy of BIO­-11006 Inhalation Solution in Patients with Acute Respiratory Distress Syndrome

Download presentation